CRP and atherosclerosis: CRP is an acute-phaseprotein synthesized by the liver in responseto inflammation.105 CRP binds to lysophosphatidylcholineon dead cells and bacteria, activating the complement pathway.106 It has been shown that elevated levels of CRPhave been linked to increased cardiovascular risk and have been proposedas a biomarker for predicting and diagnosing CVD.107 CRP can also monitor disease progression and treatmentresponse in patients with atherosclerosis and other inflammatory.108−110